![]() |
Lung Cancer |
Free Subscription
3 Ann Oncol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Lung Cancer is free of charge.
Letter to the Editor: Comments on the study of lung cancer detection by
electronic nose analysis of exhaled breath.
Ann Oncol. 2025 May 12:S0923-7534(25)00196-6. doi: 10.1016/j.annonc.2025.
PubMed
Validation Study of Electronic Nose Detection for Lung Cancer.
Ann Oncol. 2025 May 12:S0923-7534(25)00197-8. doi: 10.1016/j.annonc.2025.
PubMed
Letter Re: Lung cancer detection by electronic nose analysis of exhaled breath: a
multi-center prospective external validation study.
Ann Oncol. 2025 May 12:S0923-7534(25)00195-4. doi: 10.1016/j.annonc.2025.
PubMed
Development and Validation of a Machine Learning-Based Predictive Model for
Postoperative Frailty in Patients with Non-Small Cell Lung Cancer and Its
Relation to Early Recovery.
Ann Surg Oncol. 2025 May 14. doi: 10.1245/s10434-025-17353.
PubMed
Abstract available
High catchment areas for lung cancer screening-eligible patients.
Ann Thorac Surg. 2025 May 13:S0003-4975(25)00414.
PubMed
Abstract available
Safety and efficacy of rechallenge with immune checkpoint inhibitors and
anlotinib in advanced non-small cell lung cancer without targetable driver
mutations: a retrospective analysis.
BMC Cancer. 2025;25:862.
PubMed
Abstract available
The impact of EGFR mutation and PD-L1 status on the efficacy of postoperative
radiotherapy in stage III-pN2 NSCLC.
BMC Cancer. 2025;25:858.
PubMed
Abstract available
Novel PET imaging biomarkers as predictors of postoperative recurrence in lung
adenocarcinoma.
BMC Cancer. 2025;25:874.
PubMed
Abstract available
Cost-effectiveness of one-off upper abdominal CT screening as an add-on to lung
cancer screening in England.
Br J Cancer. 2025 May 14. doi: 10.1038/s41416-025-03043.
PubMed
Abstract available
Survival outcomes of pulmonary metastasis-directed local therapy in adenoid
cystic carcinoma.
Cancer. 2025;131:e35901.
PubMed
Abstract available
Anlotinib in combination with docetaxel for advanced nonsmall cell lung cancer
after failure of platinum-based treatment: A phase 1/2 trial.
Cancer. 2025;131:e35822.
PubMed
Abstract available
Circular RMST cooperates with lineage-driving transcription factors to govern
neuroendocrine transdifferentiation.
Cancer Cell. 2025;43:891-904.
PubMed
Abstract available
A circular RNA in neuroendocrine carcinomas.
Cancer Cell. 2025;43:812-814.
PubMed
Abstract available
Mechanistic Insights into CLNS1A-Mediated Chemoresistance and Tumor Progression
in Non-small Cell Lung Cancer.
Cancer Lett. 2025 May 7:217783. doi: 10.1016/j.canlet.2025.217783.
PubMed
Abstract available
Loss of SPHK1 fuels inflammation to drive KRAS-mutated lung adenocarcinoma.
Cancer Lett. 2025;623:217733.
PubMed
Abstract available
HDAC4 super-enhancer drives CEBPB-mediated TWIST2 transcription to promote
chemoresistance in LUAD.
Cancer Lett. 2025;623:217716.
PubMed
Abstract available
Tobacco Smoking Rewires Cell Metabolism by Inducing GAPDH Succinylation to
Promote Lung Cancer Progression.
Cancer Res. 2025 May 14. doi: 10.1158/0008-5472.CAN-24-3525.
PubMed
Abstract available
MYLK-AS1 Enhances Glutamine Metabolism to Promote EGFR Inhibitor Resistance in
Non-Small Cell Lung Cancer.
Cancer Res. 2025 May 14. doi: 10.1158/0008-5472.CAN-23-3748.
PubMed
Abstract available
"Dr. Jekyll and Mr. Hyde": AT2 Cells in Lung Regeneration and Tumor Development.
Cancer Res. 2025;85:1753-1754.
PubMed
Abstract available
Genetic susceptibility to lung squamous cell carcinoma: new insights on 9q33.2
variants and tobacco smoking.
Carcinogenesis. 2025;46:bgaf018.
PubMed
Abstract available
The Impact of Healthcare Disparities on Lung Cancer Screening and Treatment.
Chest. 2025 May 9:S0012-3692(25)00573-2. doi: 10.1016/j.chest.2025.
PubMed
Abstract available
A 7-Year-Old Girl With Multiple Pulmonary Nodules.
Chest. 2025;167:e161-e165.
PubMed
Abstract available
Practice Patterns and Patient Travel Distances for Lung Cancer Surgery in the
United States: Analyses of the Veterans Health Administration and the National
Cancer Database.
Chest. 2025 May 8:S0012-3692(25)00563-X. doi: 10.1016/j.chest.2025.
PubMed
Lung Cancer Screening Adherence in Centralized versus Decentralized Screening
Programs A Meta-Analysis of U.S. Cohort Studies Among Individuals with Negative
Baseline Results.
Chest. 2025 May 7:S0012-3692(25)00559-8. doi: 10.1016/j.chest.2025.
PubMed
Abstract available
Neighborhood-Level Socioeconomic Disadvantage and Adherence to Guidelines for the
Evaluation of Patients With Incidentally Detected Pulmonary Nodules.
Chest. 2025;167:1497-1508.
PubMed
Abstract available
Dietary Pattern, Sputum DNA Methylation, and Lung Health: An Epidemiological
Study in People Who Ever Smoked.
Chest. 2025;167:1333-1345.
PubMed
Abstract available
Brief Report: The Genomic Landscape of Small Cell Lung Cancer in Never-Smoking
Patients.
Clin Lung Cancer. 2025 Mar 31:S1525-7304(25)00057.
PubMed
Abstract available
Assessment of Lung Cancer Risks Related to Family History in Never-Smokers: A
Cohort Study.
Clin Lung Cancer. 2025 Apr 8:S1525-7304(25)00061.
PubMed
Abstract available
Comment on: Association of Sarcopenia with Toxicity and Survival in Patients With
Lung Cancer, a Multi-Institutional Study With External Dataset Validation.
Clin Lung Cancer. 2025 Apr 14:S1525-7304(25)00075.
PubMed
Common Medical Comorbidities Influence Pneumonitis Risk After Chemoradiotherapy
and Durvalumab Maintenance in Stage III Non-small Cell Lung Cancer.
Clin Lung Cancer. 2025 Apr 24:S1525-7304(25)00082.
PubMed
Abstract available
[Corrigendum] New application of an old drug: Antitumor activity and mechanisms
of doxycycline in small cell lung cancer.
Int J Oncol. 2025;66:48.
PubMed
Abstract available
Thoracoscopy-guided thoracic paravertebral block using dexmedetomidine in
combination with ropivacaine for postoperative analgesia after thoracoscopic
radical resection of lung cancer: a randomized controlled trial.
J Cancer Res Clin Oncol. 2025;151:158.
PubMed
Abstract available
ST6GalNAc-I regulates tumor cell sialylation via NECTIN2/MUC5AC-mediated
immunosuppression and angiogenesis in non-small cell lung cancer.
J Clin Invest. 2025;135:e186863.
PubMed
Abstract available
In Situ Detection of Programmed Cell Death Protein 1 and Programmed Death Ligand
1 Interactions as a Functional Predictor for Response to Immune Checkpoint
Inhibition in NSCLC.
J Thorac Oncol. 2025;20:625-640.
PubMed
Abstract available
Diabetic Ketoacidosis During Lorlatinib Treatment: Case Report.
J Thorac Oncol. 2025;20:676-679.
PubMed
Abstract available
Treatment sequences in BRAF-V600-mutated non-small cell lung cancer: First-line
targeted therapy versus first-line (chemo-) immunotherapy.
J Thorac Oncol. 2025 May 7:S1556-0864(25)00706.
PubMed
Abstract available
The Tree That Let Us See the Forest: The Importance of Comorbidities in Lung
Cancer Screening Programs.
J Thorac Oncol. 2025;20:555-556.
PubMed
Lung Cancer in Tanzania.
J Thorac Oncol. 2025;20:560-564.
PubMed
Refining Surgical Decision-Making for Elderly Patients With Lung Cancer:
Recognized Risks, Unmet Needs.
J Thorac Oncol. 2025;20:e62-e63.
PubMed
Response to Letter to the Editor: "Refining Surgical Decision-Making for Elderly
With Lung Cancer Patients: Recognized Risks, Unmet Needs".
J Thorac Oncol. 2025;20:e63-e64.
PubMed
Emerging Role of Targeted Therapies Combined with Radiotherapy in Inoperable
Stage I-III, Non-Small Cell Lung Cancer (NSCLC): A Review from the International
Association for the Study of Lung Cancer (IASLC) Advanced Radiation Technology
(ART) Subcommi
J Thorac Oncol. 2025 May 9:S1556-0864(25)00710.
PubMed
Abstract available
Prognostic and predictive effects of TP53 co-mutation in patients with non-small
cell lung cancer with rare treatable driver mutations.
Lung Cancer. 2025;204:108452.
PubMed
Abstract available
Genomic profiling of aggressive pathologic features in lung adenocarcinoma.
Lung Cancer. 2025;203:108460.
PubMed
Abstract available
Frequency of targetable genetic alterations in resectable lung adenocarcinoma:
Results from the LORD project.
Lung Cancer. 2025;203:108530.
PubMed
Abstract available
The global burden of mesothelioma and its association with asbestos bans,
1990-2021: a population-based study.
Lung Cancer. 2025;203:108534.
PubMed
Abstract available
Efficacy and safety of bintrafusp alfa evaluated in a phase II single-arm
clinical trial in previously treated advanced pleural mesothelioma.
Lung Cancer. 2025;203:108545.
PubMed
Abstract available
Concurrent immunotherapy improves progression-free survival but increases
toxicity in unresectable stage III NSCLC.
Lung Cancer. 2025;203:108544.
PubMed
Abstract available
Decision-making tree model for distinguishing between benign and malignant
subpleural pulmonary lesions based on ultrasonic strain elastography.
Lung Cancer. 2025;203:108547.
PubMed
Abstract available
Real-world outcomes of subsequent treatment strategies after durvalumab
consolidation in stage III unresectable non-small cell lung cancer.
Lung Cancer. 2025;204:108576.
PubMed
Abstract available
Association of thyroid radiation dose with thyroid dysfunction in patients with
locally advanced non-small cell lung cancer treated with concurrent
chemoradiotherapy followed by maintenance immunotherapy.
Lung Cancer. 2025;204:108574.
PubMed
Abstract available
Impact of durvalumab re-administration after moderate symptomatic pneumonitis in
locally advanced non-small cell lung cancer.
Lung Cancer. 2025;204:108578.
PubMed
Abstract available
Feasibility, acceptability and clinical outcomes of a real-world, regional lung
cancer prehabilitation programme for patients undergoing curative intent
radiotherapy.
Lung Cancer. 2025;204:108572.
PubMed
Abstract available
STK31 drives tumor immune evasion through STAT3-IL-6 mediated CD8(+) T cell
exhaustion.
Oncogene. 2025;44:1452-1462.
PubMed
Abstract available
Correction: TP53 mutations upregulate RCP expression via Sp1/3 to drive lung
cancer progression.
Oncogene. 2025 May 14. doi: 10.1038/s41388-025-03441.
PubMed
RNA?binding protein MBNL1 regulates tumor growth, chemosensitivity and antitumor
immunity in lung adenocarcinoma by controlling the expression of tumor suppressor
RNF125.
Oncol Rep. 2025;54:74.
PubMed
Abstract available
Efficacy and safety of dacomitinib in treatment-naive patients with advanced
NSCLC and brain metastasis: a multicenter cohort study.
Oncologist. 2025;30:oyaf079.
PubMed
Abstract available
Palliative and end-of-life care in Asian and White patients with metastatic lung
cancer.
Oncologist. 2025;30:oyaf065.
PubMed
Abstract available
Diagnostic, prognostic, and immunological roles of FUT8 in lung adenocarcinoma
and lung squamous cell carcinoma.
PLoS One. 2025;20:e0321756.
PubMed
Abstract available
Lobectomy versus sublobar resection on survival in patients with stage T1-2N0M0
small cell lung cancer.
PLoS One. 2025;20:e0324315.
PubMed
Abstract available
Retraction: Efficient lung cancer detection using computational intelligence and
ensemble learning.
PLoS One. 2025;20:e0324356.
PubMed
Thank you for your interest in scientific medicine.